Marita Stevens

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Aortic Dissection

Respiratory Syncytial Virus

Placebo Controlled

Top Venues

Paediatric drugs

Influenza and other respiratory viruses

Patient related outcome measures

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs (2024)
Ann R Falsey, Edward E Walsh, Stacey L House, Yannick Vandendijck, Marita Stevens, Eric K H Chan, Gabriela Ispas
Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus. Influenza and other respiratory viruses 18 (5) (2024)
Ann R Falsey, Edward E Walsh, Stacey L House, Yannick Vandendijck, Marita Stevens, Eric K H Chan, Gabriela Ispas
Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus. Influenza and other respiratory viruses 18 (5) (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)
Christine de la Loge, Fatoumata Fofana, Paul Williams, Sarah Rusch, Marita Stevens, Jane Scott
Monitoring Severity of Respiratory Syncytial Virus (RSV) in Infants and Young Children Using the Pediatric RSV Electronic Severity and Outcome Rating System (PRESORS): Results of Initial Quantitative Validation. Patient related outcome measures 12 (2021)